BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

722 related articles for article (PubMed ID: 21916843)

  • 21. Exploring the possible link between MeCP2 and oxidative stress in Rett syndrome.
    Filosa S; Pecorelli A; D'Esposito M; Valacchi G; Hajek J
    Free Radic Biol Med; 2015 Nov; 88(Pt A):81-90. PubMed ID: 25960047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical profiles of four patients with Rett syndrome carrying a novel exon 1 mutation or genomic rearrangement in the MECP2 gene.
    Bartholdi D; Klein A; Weissert M; Koenig N; Baumer A; Boltshauser E; Schinzel A; Berger W; Mátyás G
    Clin Genet; 2006 Apr; 69(4):319-26. PubMed ID: 16630165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synaptic plasticity deficits in an experimental model of rett syndrome: long-term potentiation saturation and its pharmacological reversal.
    Weng SM; McLeod F; Bailey ME; Cobb SR
    Neuroscience; 2011 Apr; 180():314-21. PubMed ID: 21296130
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The ups and downs of BDNF in Rett syndrome.
    Sun YE; Wu H
    Neuron; 2006 Feb; 49(3):321-3. PubMed ID: 16446133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hippocampal synaptic plasticity is impaired in the Mecp2-null mouse model of Rett syndrome.
    Asaka Y; Jugloff DG; Zhang L; Eubanks JH; Fitzsimonds RM
    Neurobiol Dis; 2006 Jan; 21(1):217-27. PubMed ID: 16087343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glatiramer acetate (GA, Copolymer-1) an hypothetical treatment option for Rett syndrome.
    Ben-Zeev B; Aharoni R; Nissenkorn A; Arnon R
    Med Hypotheses; 2011 Feb; 76(2):190-3. PubMed ID: 20951500
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MeCP2 in neurons: closing in on the causes of Rett syndrome.
    Caballero IM; Hendrich B
    Hum Mol Genet; 2005 Apr; 14 Spec No 1():R19-26. PubMed ID: 15809268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Associations between MeCP2 mutations, X-chromosome inactivation, and phenotype.
    Hoffbuhr KC; Moses LM; Jerdonek MA; Naidu S; Hoffman EP
    Ment Retard Dev Disabil Res Rev; 2002; 8(2):99-105. PubMed ID: 12112735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeted delivery of an Mecp2 transgene to forebrain neurons improves the behavior of female Mecp2-deficient mice.
    Jugloff DG; Vandamme K; Logan R; Visanji NP; Brotchie JM; Eubanks JH
    Hum Mol Genet; 2008 May; 17(10):1386-96. PubMed ID: 18223199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MeCP2 R168X male and female mutant mice exhibit Rett-like behavioral deficits.
    Schaevitz LR; Gómez NB; Zhen DP; Berger-Sweeney JE
    Genes Brain Behav; 2013 Oct; 12(7):732-40. PubMed ID: 24283265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation mechanism and research progress of MeCP2 in Rett syndrome.
    Yang W; Pan H
    Yi Chuan; 2014 Jul; 36(7):625-30. PubMed ID: 25076025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MeCP2 Rett mutations affect large scale chromatin organization.
    Agarwal N; Becker A; Jost KL; Haase S; Thakur BK; Brero A; Hardt T; Kudo S; Leonhardt H; Cardoso MC
    Hum Mol Genet; 2011 Nov; 20(21):4187-95. PubMed ID: 21831886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological reactivation of inactive X-linked
    Przanowski P; Wasko U; Zheng Z; Yu J; Sherman R; Zhu LJ; McConnell MJ; Tushir-Singh J; Green MR; Bhatnagar S
    Proc Natl Acad Sci U S A; 2018 Jul; 115(31):7991-7996. PubMed ID: 30012595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective preservation of cholinergic MeCP2 rescues specific Rett-syndrome-like phenotypes in MeCP2
    Zhou H; Wu W; Zhang Y; He H; Yuan Z; Zhu Z; Zhao Z
    Behav Brain Res; 2017 Mar; 322(Pt A):51-59. PubMed ID: 28093257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FXYD1 is an MeCP2 target gene overexpressed in the brains of Rett syndrome patients and Mecp2-null mice.
    Deng V; Matagne V; Banine F; Frerking M; Ohliger P; Budden S; Pevsner J; Dissen GA; Sherman LS; Ojeda SR
    Hum Mol Genet; 2007 Mar; 16(6):640-50. PubMed ID: 17309881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disruption of DNA-methylation-dependent long gene repression in Rett syndrome.
    Gabel HW; Kinde B; Stroud H; Gilbert CS; Harmin DA; Kastan NR; Hemberg M; Ebert DH; Greenberg ME
    Nature; 2015 Jun; 522(7554):89-93. PubMed ID: 25762136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice.
    Chen RZ; Akbarian S; Tudor M; Jaenisch R
    Nat Genet; 2001 Mar; 27(3):327-31. PubMed ID: 11242118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of DNA Methyl-CpG-Binding Protein MeCP2 in Rett Syndrome Pathobiology and Mechanism of Disease.
    Pejhan S; Rastegar M
    Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33429932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activity and MeCP2-dependent regulation of nNOS levels in enteric neurons.
    Wahba G; Schock SC; Cudd S; Grynspan D; Humphreys P; Staines WA
    Neurogastroenterol Motil; 2016 Nov; 28(11):1723-1730. PubMed ID: 27254746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered somatosensory barrel cortex refinement in the developing brain of Mecp2-null mice.
    Moroto M; Nishimura A; Morimoto M; Isoda K; Morita T; Yoshida M; Morioka S; Tozawa T; Hasegawa T; Chiyonobu T; Yoshimoto K; Hosoi H
    Brain Res; 2013 Nov; 1537():319-26. PubMed ID: 24060648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.